image
BeiGene, Ltd. BGNE
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 189.23
-2.1 %
$ 21 B
Market Cap
-23.08
P/E
FINANCIAL REPORTS

Reports

Report Date Revenue YoY Net Income YoY Operating Income YoY View
Annual Report FY 10-K 2023-12-31 73.65% 56.00% 32.52%
Annual Report FY 10-K 2022-12-31 20.37% -41.78% -24.39%
Annual Report FY 10-K 2021-12-31 280.83% 11.69% 13.21%
Annual Report FY 10-K 2020-12-31 -27.87% -68.37% -72.69%
Annual Report FY 10-K 2019-12-31 116.03% -41.08% -36.01%
Annual Report FY 10-K 2018-12-31 -16.85% -623.67% -616.83%
Annual Report FY 10-K 2017-12-31 22179.16% 21.90% 15.89%
Annual Report FY 10-K 2016-12-31 -87.86% -108.78% -106.29%
Annual Report FY 10-K 2015-12-31 -32.37% -212.41% -260.13%
Annual Report FY 10-K 2014-12-31 16.93% -143.90% -188.70%
Annual Report FY 10-K 2013-12-31 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2024-06-30 56.09% 68.41% 66.38%
Quarterly Report Q1 8-K 2024-03-31 67.85% 27.92% 29.60%
Quarterly Report Q4 8-K 2023-12-31 66.91% 17.47% 18.10%
Quarterly Report Q3 8-K 2023-09-30 101.56% 138.64% 69.44%
Quarterly Report Q2 8-K 2023-06-30 74.27% 33.30% 27.47%
Quarterly Report Q1 8-K 2023-03-31 46.04% 19.77% 16.25%
Quarterly Report Q4 8-K 2022-12-31 77.63% 23.96% 20.14%
Quarterly Report Q3 8-K 2022-09-30 87.77% -34.72% 5.18%
Quarterly Report Q2 8-K 2022-06-30 127.73% -18.97% 7.46%
Quarterly Report Q1 8-K 2022-03-31 -49.39% -653.09% -631.76%
Quarterly Report Q4 8-K 2021-12-31 113.77% -23.88% -21.01%
Quarterly Report Q3 8-K 2021-09-30 126.66% 2.67% -5.04%
Quarterly Report Q2 8-K 2021-06-30 128.52% -43.30% -32.31%
Quarterly Report Q1 8-K 2021-03-31 1063.82% 118.28% 118.77%
Quarterly Report Q4 8-K 2020-12-31 75.95% -21.82% -24.97%
Quarterly Report Q3 8-K 2020-09-30 81.65% -38.35% -40.95%
Quarterly Report Q2 8-K 2020-06-30 -73.03% -291.73% -318.11%
Quarterly Report Q1 8-K 2020-03-31 -33.11% -116.97% -115.11%
Quarterly Report Q4 8-K 2019-12-31 -3.03% -44.66% -38.19%
Quarterly Report Q3 8-K 2019-09-30 -7.49% -113.40% -106.66%
Quarterly Report Q2 8-K 2019-06-30 360.85% 45.46% 47.36%
Quarterly Report Q1 8-K 2019-03-31 139.16% -60.27% -56.81%
Quarterly Report Q4 8-K 2018-12-31 222.82% -170.08% -170.53%
Quarterly Report Q3 8-K 2018-09-30 -75.39% -122.70% -131.50%
Quarterly Report Q2 8-K 2018-06-30 0.00% -159.12% -181.01%
Quarterly Report Q1 8-K 2018-03-31 0.00% -106.62% -114.99%
Quarterly Report Q4 8-K 2017-12-31 -86.75% -164.17% -178.50%
Quarterly Report Q3 8-K 2017-09-30 0.00% 430.72% 429.92%
Quarterly Report Q2 8-K 2017-06-30 0.00% -150.97% -135.59%
Quarterly Report Q1 8-K 2017-03-31 0.00% -130.09% -153.48%
Quarterly Report Q4 8-K 2016-12-31 2832.01% -37.97% -41.30%
Quarterly Report Q3 8-K 2016-09-30 0.00% -153.55% -148.91%
Quarterly Report Q2 8-K 2016-06-30 -71.52% -327.65% -275.14%
Quarterly Report Q1 8-K 2016-03-31 -50.91% -115.44% -107.24%
Quarterly Report Q4 8-K 2015-12-31 238.67% -626.47% -308.74%
Quarterly Report Q3 8-K 2015-09-30 -78.76% -43.45% -144.62%
Quarterly Report Q2 8-K 2015-06-30 -46.49% -136.62% -266.35%
Quarterly Report Q1 8-K 2015-03-31 -46.53% -328.36% -447.54%
Quarterly Report Q4 8-K 2014-12-31 0.00% 0.00% 0.00%
Quarterly Report Q3 8-K 2014-09-30 0.00% 0.00% 0.00%
Quarterly Report Q2 8-K 2014-06-30 0.00% 0.00% 0.00%
Quarterly Report Q1 8-K 2014-03-31 0.00% 0.00% 0.00%